Literature DB >> 19722700

Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles.

Noriko Murakami1, David Bolton, Yu-Wen Hwang.   

Abstract

In spite of a nuclear targeting sequence, a substantial amount of dual-specificity tyrosine phosphorylation-regulated kinase (Dyrk1A) is located within the cytoplasm of neurons. Analysis of fractionated rat brains revealed that the majority of Dyrk1A was in the postnuclear precipitate. The kinase in this fraction was resistant to high salt and Triton X-100 extraction at pH 6.5. Hypothesizing that Dyrk1A binds tightly with cell constituents, we searched for Dyrk1A binding proteins in the Triton X-100-insoluble fraction extracted with urea and fractionated by column chromatography. An overlay assay using the recombinant kinase revealed that multiple proteins are capable of binding to Dyrk1A. Among them, we identified clathrin heavy chain and dynamin 1 as potential candidates. An overlay assay using purified and partially purified proteins showed the binding of Dyrk1A with both proteins. Under native conditions, Dyrk1A precipitated with newly formed clathrin cages and with dynamin via the GST-amphiphysin SH3 domain. We also identified another endocytic protein, endophilin 1, as an additional Dyrk1A binding protein. We then tested whether the clathrin-coated vesicle (CCV)-associated proteins could be phosphorylated by Dyrk1A. Multiple proteins apparently distinctive from the known substrates were phosphorylated in the brain CCV. Our findings suggest a role for Dyrk1A in controlling synaptic vesicle recycling processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19722700     DOI: 10.1021/bi9010557

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Tatyana Adayev; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

2.  Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Jessica Gall; Lizzy George; Rachel Nosheny; Michael T Maloney; Ahmad Salehi; William C Mobley
Journal:  Neurobiol Dis       Date:  2011-10-17       Impact factor: 5.996

3.  Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.

Authors:  Karol Dowjat; Tatyana Adayev; Wojciech Kaczmarski; Jerzy Wegiel; Yu-Wen Hwang
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

4.  DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome.

Authors:  Jianxing Xiang; Su Yang; Ning Xin; Marta A Gaertig; Roger H Reeves; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 5.  The role of DYRK1A in neurodegenerative diseases.

Authors:  Jerzy Wegiel; Cheng-Xin Gong; Yu-Wen Hwang
Journal:  FEBS J       Date:  2010-12-13       Impact factor: 5.542

6.  DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons.

Authors:  Iván Fernandez Bessone; Jordi Navarro; Emanuel Martinez; Karina Karmirian; Mariana Holubiec; Matias Alloatti; Livia Goto-Silva; Cayetana Arnaiz Yepez; Daniel Martins-de-Souza; Juliana Minardi Nascimento; Luciana Bruno; Trinidad M Saez; Stevens K Rehen; Tomás L Falzone
Journal:  J Neurosci       Date:  2022-07-08       Impact factor: 6.709

7.  Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Authors:  Wojciech Kaczmarski; Madhabi Barua; Bozena Mazur-Kolecka; Janusz Frackowiak; Wieslaw Dowjat; Pankaj Mehta; David Bolton; Yu-Wen Hwang; Ausma Rabe; Giorgio Albertini; Jerzy Wegiel
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

8.  Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation.

Authors:  Noriko Murakami; David C Bolton; Elizabeth Kida; Wen Xie; Yu-Wen Hwang
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 9.  DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.

Authors:  Arnaud Duchon; Yann Herault
Journal:  Front Behav Neurosci       Date:  2016-06-03       Impact factor: 3.558

10.  K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR.

Authors:  Pengshan Zhang; Zhe Zhang; Yinkun Fu; Ying Zhang; Michael P Washburn; Laurence Florens; Min Wu; Chen Huang; Zhaoyuan Hou; Man Mohan
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.